The Tropical Disease Foundation, Inc. (TDF) is a private, non-stock, non-profit organization founded in 1984 by a group of physicians in the Research Institute for Tropical Medicine. The founding chairman was Dr. Jesus Azurin, then Secretary of Health. Through a Memorandum of Agreement with the Makati Medical Center (MMC) in 1987, the TDF transferred to the MMC and Dr. Constantino P. Manahan was elected as the Chairman of the TDF Board of Trustees. The current chairman of the Board is Dr. Jose C. Benitez.
Through the generosity of donors and friends, TDF inaugurated its research laboratory on mycobacteriology, including fluorescent sputum smear microscopy, TB culture, and drug sensitivity testing, on 2 February 1988. The launch was graced by the presence of Professor Calvin M. Kunin and Dr. Constantino P. Manahan. With these laboratory facilities, the TDF was able to pursue its activities in training and research in tropical infectious diseases.
The TDF fulfilled several major accomplishments in its research of various diseases.
In 1988, the TDF published the first edition of the Guidelines on Anti-Microbial Therapy. One year later, Dr. Roberta Romero headed research on leprosy. Throughout the 1990s, research was conducted on hepatitis B, herpes simplex, rubeola, and multi-drug resistant typhoid fever. Additionally, TDF employees gave trainings and built capacity in these diseases.
In 1997, the Tropical Disease Foundation was commissioned by the Department of Health to do the Nationwide TB Prevalence Survey. TDF was given the 2000 Outstanding Health Research Award. This also initiated the close collaboration between the TDF and the National TB Control Program of the Department of Health through the initiation of the DOTS Clinic at the Makati Medical Center. This private-public collaboration provides free service in the management of TB patients and was the first DOTS-Plus pilot project approved by the WHO Green Light Committee for the management of multi-drug resistant TB.
In 2003, the Foundation was awarded resources by the Global Fund to fight TB, malaria and HIV. As its Principal recipient from 2003 to 2009, the foundation carried out programs dedicated to these diseases. Foremost in its notable efforts, the foundation pioneered the establishment of multiple centers capable of the diagnosis and treatment of Multidrug Resistant Tuberculosis.
TDF remains a leader in research, particularly in tuberculosis. In 2007, TDF led the 3rd Nationwide Tuberculosis Prevalence Survey, from which data and information on the status of TB prevalence in the Philippines was derived. The findings from the NTPS have been the basis for the national TB program and subsequent studies.
As it moves forward, TDF continues to find new ways to exercise its core competencies in service, research, and training and to expand its horizons. By expanding its reach from international clinical studies to local community services, TDF’s work is consistent in its vision for an economically productive and healthy Philippines.
Posted by admin on September 25th, 2009 under TDF PR